Introduction
============

Air pollution is a major public health hazard, particularly in developing countries \[[@B1]\]. Air pollution is defined as the presence of foreign substances in the air that affect the health and well-being of living beings \[[@B2]\]. As the world progresses, air pollution has become a major problem that has to be faced. This problem is likely to have adverse effects on health, even when pollutant levels are within the standards required by legislation.

There has been considerable interest in recent years in the health effects of exposure to both short-term fluctuations and long-term levels of air pollution, in particular common environmental pollutants including particulate matter (PM), ozone (O~3~), carbon monoxide (CO), nitrogen dioxide (NO~2~) and sulphur dioxide (SO~2~) \[[@B3]\]. The potentially deleterious effect of episodes of high air pollution on health has been suspected for more than 50 years \[[@B4]\].

Since the 1990s, many epidemiological studies have demonstrated associations between air pollution levels and human health in terms of hospital admissions \[[@B5][@B6]\]. Air pollution are positively associated with hospital admission for cardiovascular disease \[[@B3]\], respiratory disease \[[@B7]\], and gastrointestinal disease \[[@B8]\].

Further understanding about the association of the air pollution and hospital admission will help the policy maker to understand the seriousness of the effect of air pollution thus helping them in planning and strategizing their health system. It will help them in reorganize their resources so they can anticipate the trend of hospital admission cases that was cause by the air pollution.

The aim of this study was to systematically review the evidence concerning air pollution effects on the risk of hospital admission. We hypothesised that increases in PM, O~3~, CO, NO~2~, and SO~2~ levels would be associated with the increasing trend of hospital admission. We would also like to see the diseases that were affected by the air pollution and the components in the air pollution that cause the hospital admission.

Method
======

Database and sources
--------------------

We searched five large databases covering health and medical literature which are Sage, Ovid Medline, Science Direct, Wiley, and ProQuest. Articles retrieved were those that were published from 2010 to 2016. Reference lists of all relevant studies were scanned to identify any further studies, and if these revealed that search terms had been missed, extra terms were added to the main database searches. Conference abstracts and unpublished studies were not included in this review.

Search keywords and terms
-------------------------

Our search of database used the following keywords "hospital admission and air pollution". All sub-terms were also included and we limited the search to studies of humans, published in English.

Inclusion and exclusion criteria
--------------------------------

To examine the hypothesis that ambient air pollutant exposure would be associated with risk of hospitalization, studies of any relevant design were included if they presented original data, and included at least one analysis where hospital admission was the specific outcome, and one or more of the following exposures were investigated: PM, O~3~, CO, NO~2~, and SO~2~. We excluded studies in which the authors did not control for (or stratify by) any potential confounding factors or did not report measures of precision or *p* values for the analysis of interest.

Procedure
---------

Titles and abstracts were screened for relevance, and full-text versions obtained where appropriate for assessment with reference to the inclusion and exclusion criteria; we were able to obtain full-text papers in all cases where required and it was not necessary to contact specific authors. For each study included, the following information was recorded based on prior beliefs about key aspects of study methodology and in order to summarise study quality: study design, study population, event of interest, number included, location and setting, time period, exposure variables, adjustment for weather variables, and other potential confounders, lags considered. The main results of each study were also recorded -- in particular, the effects of each pollutant of interest on risk of hospitalization, including effect sizes and confidence intervals where possible.

Flow diagram of the search study are shown in Figure [1](#F1){ref-type="fig"} below.

![Search results and selection of studies for systematic review.](agh-84-4-2376-g1){#F1}

Results
=======

From the 22 articles, nine were time-series (TS) study design, five cohort, five case-crossover (CCO), two retrospective cross-sectional (RCS), and one combination of time series and case-crossover study. Some of the studies focus on the hospital admission of certain group of disease such as cardiovascular and respiratory, while some of them more directly focus on the certain diseases. Table [1](#T1){ref-type="table"} below showed the studies that were involved in this systemic review.

###### 

Studies that were involved in this systemic review.

  ---- --------------------------------------- -------------- ----------- ------------------------------- -----------------------------------------
  No   Study                                   Study period   Location    Study design                    Health effect

                                                                                                          

  1    Montresor-López et al. 2015 \[[@B9]\]   2002--2006     US          Case-crossover                  Stroke admission

  2    Cheng et al. 2015 \[[@B10]\]            2006--2010     Taiwan      Case-crossover                  COPD admission\
                                                                                                          Asthma admission\
                                                                                                          Pneumonia admission

  3    Milojevic et al. 2014 \[[@B11]\]        2003--2009     England     Case-crossover                  CVS admission\
                                                                                                          Atrial fibrillation\
                                                                                                          Arrhythmia\
                                                                                                          Heart failure

  4    Iskandar et al. 2011 \[[@B12]\]         2001--2008     Denmark     Case-crossover                  Asthma admission

  5    Ghozikali et al. 2015 \[[@B13]\]        2008--2009     Iran        Case-crossover                  COPD admission

  6    Wong et al. 2016 \[[@B8]\]              1998--2001     Hong Kong   Cohort                          Peptic ulcer admission\
                                                                                                          Gastric ulcer\
                                                                                                          Duodenal ulcer

  7    Tonne et al. 2016 \[[@B14]\]            2003--2007     London      Cohort                          Readmission of Myocardial infarction

  8    Atkinson et al. 2014 \[[@B15]\]         2003--2007     London      Cohort                          COPD admission

  9    Andersen et al. 2011 \[[@B16]\]         1993--2006     Denmark     Cohort                          COPD admission

  10   Andersen et al. 2012 \[[@B17]\]         1993--2007     Denmark     Cohort                          Asthma admission

  11   Alimohammadi et al. 2016 \[[@B18]\]     2012--2013     Iran        Retrospective cross sectional   Ischaemic stroke admission

  12   Mansourian et al. 2010 \[[@B19]\]       2005--2006     Iran        Retrospective cross sectional   Respiratory admission

  13   Ferreira et al. 2016 \[[@B20]\]         2010--2011     Brazil      Times-series                    Respiratory admission\
                                                                                                          CVS Admission

  14   Phung et al. 2016 \[[@B21]\]            2004--2007     Vietnam     Times-series                    Respiratory admission\
                                                                                                          CVS Admission

  15   Vidotto et al. 2012 \[[@B22]\]          2000--2007     Brazil      Times-series                    Paediatric rheumatic diseases admission

  16   Kollanus et al. 2016 \[[@B23]\]         2001--2010     Finland     Times-series                    CVS admission\
                                                                                                          Respiratory admission

  17   Oudin et al. 2010 \[[@B24]\]            2001--2005     Sweden      Times-series                    Ischaemic stroke admission

  18   Vidale et al. 2010 \[[@B25]\]           2000--2003     Italy       Times-series                    Ischaemic stroke admission

  19   Jevtić et al. 2014 \[[@B26]\]           2007--2009     Serbia      Times-series                    CVS admission

  20   Xie et al. 2014 \[[@B27]\]              2010--2012     China       Times-series                    IHD admission

  21   Zhang et al. 2014 \[[@B28]\]            2008--2011     China       Times-series                    Hospital admission\
                                                                                                          Respiratory admission\
                                                                                                          Stroke admission

  22   Chen et al. 2016 \[[@B29]\]             2003--2013     Adelaide    Times-series & case-crossover   Asthma admission
  ---- --------------------------------------- -------------- ----------- ------------------------------- -----------------------------------------

*Note*: CVS: Cardiovascular; IHD: Ischaemic Heart Disease; COPD: Chronic Obstructive Pulmonary Disease.

The trend of hospitalization
----------------------------

The air pollution has cause the increasing trend of hospitalization. Air pollution was noted to have an excessive risk of 3.46 (95% CI, 1.67, 5.27) of total hospital admissions \[[@B28]\]. Most other studies shown the increasing trend of hospitalization by the disease group such as cardiovascular admission and respiratory admission.

Cardiovascular admission was noted to have an increased risk of hospitalization between 1.5 to 2.0 for PM~2.5~ \[[@B20][@B23]\]; (1.007 to 2.7) for PM~10~ \[[@B20][@B21]\]; (1.04 to 1.17) for NO~2~ \[[@B11][@B21][@B26]\] and 1.007 for SO~2~ \[[@B21]\].

For respiratory admission, PM~2.5~ can caused an increased risk of hospitalization by 1.1 to 1.8 \[[@B20][@B23]\]; (1.007 to 1.13) for PM~10~ \[[@B20][@B21]\]; (1.08 to 1.94) for NO~2~ \[[@B21][@B28]\] and 1.02 for SO~2~ \[[@B21]\].

The rest of the studies showed the effect of the air pollutant to certain disease such as asthma, pneumonia, stroke, and others are shown in Table [2](#T2){ref-type="table"}.

###### 

Effect of the pollutant to hospitalization.

  ----------- ------------------------------- ----------------------------------- -------------- -----------------------------
  Pollutant   Health effect                   RR/OR/HR (95% CI)                   Study design   Study

                                                                                                 

  PM~2.5~     Respiratory admission           RR 8.5% (--6.8, 26.3)               TS             Ferreira et al. 2016

                                              RR 10.5% (--2.2, 24.8)              TS             Kollanus et al. 2016

              Asthma admission                RR 30.2% (13.4, 49.6)\              TS & CCO       Chen et al. 2016
                                              OR 1.229 (1.139, 1.327)                            

                                              OR 1.09 (1.04, 1.13)                CCO            Iskandar et al. 2011

                                              OR 1.10 (1.06, 1.13)                CCO            Cheng et al. 2015

              COPD Admission                  OR 1.11 (1.09, 1.13)                CCO            Cheng et al. 2015

                                              HR 1.05 (0.98, 1.13)                Cohort         Atkinson et al. 2014

              Pneumonia admission             OR 1.12 (1.11, 1.13)                CCO            Cheng et al. 2015

              CVS Admission                   RR 19.6% (6.4, 34.6)                TS             Ferreira et al. 2016

                                              RR 1.5% (--6.9, 10.6)               TS             Kollanus et al. 2016

              Ischaemic stroke                RR 1.09 (1.03, 1.15)                RCS            Alimohammadi et al. 2016

              IHD admission                   RR 0.27% (0.21, 0.33)               TS             Xie et al. 2014

              MI admission                    HR 1.02 (0.98, 1.06)                Cohort         Tonne et al. 2016

              PUD admission                   HR 1.18 (1.02, 1.36)                Cohort         Wong et al. 2016

              Gastric ulcer                   HR 1.29 (1.09, 1.53)                               

              Duodenal ulcer                  HR 0.98 (0.78, 1.22)                               

  PM~10~      Respiratory admission           RR 12.8% (6.0, 20.0)                TS             Ferreira et al. 2016

                                              β coefficient = 0.63; p \< 0.001)   RCS            Mansourian et al. 2010

                                              RR 1.007 (1.002, 1.013)             TS             Phung et al. 2016

              Asthma admission                RR 8.3% (2.5, 14.4)\                TS & CCO       Chen et al. 2016
                                              OR 1.035 (1.007, 1.064)                            

                                              OR 1.04 (1.03--1.06)                CCO            Cheng et al. 2015

                                              OR 1.07 (1.03, 1.12)                CCO            Iskandar et al. 2011

              COPD Admission                  OR 1.05 (1.03--1.06)                CCO            Cheng et al. 2015

              Pneumonia admission             OR 1.05 (1.04--1.05)                CCO            Cheng et al. 2015

              CVS Admission                   RR 2.7% (--2.2, 7.9)                TS             Ferreira et al. 2016

                                              RR 1.005 (1, 1.009)                 TS             Phung et al. 2016

              Ischaemic stroke                RR 1.14 (1.06, 1.22)                RCS            Alimohammadi et al. 2016

                                              RR 13% (4, 22)                      TS             Oudin et al. 2010

                                              RR 1.078 (1.104, 1.052)             TS             Vidale et al. 2010

              MI admission                    HR 1.05 (1.00, 1.10)                Cohort         Tonne et al. 2016

  NO~2~       Respiratory admission           RR 1.08 (1.06, 1.011)               TS             Phung et al. 2016

                                              RR 1.94 (0.50, 3.40)                TS             Zhang et al. 2014

              Asthma admission                RR 12.5% (6.6, 18.7),\              TS & CCO       Chen et al. 2016
                                              OR 1.077 (1.046, 1.109)                            

                                              HR 1.12 (1.04, 1.22)                Cohort         Andersen et al. 2012

                                              OR 1.10 (1.04, 1.16)                CCO            Iskandar et al. 2011

              COPD Admission                  HR 1.06 (0.98, 1.15)                Cohort         Atkinson et al. 2014

                                              HR 1.08 (1.02, 1.14)                Cohort         Andersen et al. 2011

                                              OR 1.0038 (1.0004, 1.0094)          CCO            Ghozikali et al. 2015

              CVS Admission                   RR 1.04 (1, 1.06)                   TS             Phung et al. 2016

                                              RR 1.049 (1.009, 1.091)             TS             Jevtić et al. 2014

                                              OR 1.7% (95% CI 0.9 to 2.6)         CCO            Milojevic et al. 2014

              Ischaemic stroke                RR 1.07 (1.04, 1.1)                 RCS            Alimohammadi et al. 2016

                                              RR 1.039 (1.066, 1.013)             TS             Vidale et al. 2010

              MI admission                    HR 1.05 (0.99, 1.10)                Cohort         Tonne et al. 2016

  SO~2~       Respiratory admission           RR 1.02 (1.01, 1.03)                TS             Phung et al. 2016

                                              β coefficient = 0.59; p \< 0.001)   RCS            Mansourian et al. 2010

              COPD admission                  OR 1.0044 (1, 1.011)                CCO            Ghozikali et al. 2015

              CVS Admission                   RR 1.007 (1, 1.01)                  TS             Phung et al. 2016

              Ischaemic stroke                RR 1.08 (1.06, 1.1)                 RCS            Alimohammadi et al. 2016

              Paediatric rheumatic diseases   RR 1.98% (0.25, 3.69)               TS             Vidotto et al. 2012

  Ozone       COPD admission                  RR 1.0058 (1.0022, 1.0094)          CCO            Ghozikali et al. 2015

              Ischaemic stroke                RR 1.07 (1.03, 1.11)                RCS            Alimohammadi et al. 2016

              Stroke admission                OR 0.98 (0.96, 1.00)                CCO            Montresor-López et al. 2015
  ----------- ------------------------------- ----------------------------------- -------------- -----------------------------

*Note*: CVS: Cardiovascular; IHD: Ischaemic Heart Disease; COPD: Chronic Obstructive Pulmonary Disease; MI: Myocardial infarction; PUD: Peptic Ulcer Disease.

Type of AP that cause the hospitalization
-----------------------------------------

In this review, five air pollutant were identified that cause their own health effect. They are particulate matter less than 2.5 μm (PM~2.5~), particulate matter less than 10 μm (PM~10~), nitrogen dioxide (NO~2~), sulphur dioxide (SO~2~), and ozone. Each pollutant has their own effect to certain disease as shown by the relative risk (RR), odds ratio (OR), and hazard ratio (HR) depending on the type of the study design.

For example, PM~2.5~ has effect on asthma, pneumonia, COPD, stroke, Ischaemic heart Disease (IHD), myocardial infarct (MI), gastric ulcer, and other admission. Table [2](#T2){ref-type="table"} summarizes the effect of these pollutants.

Diseases that were affected by air pollution
--------------------------------------------

From this review, several diseases were identified that has association with the air pollutants. For certain disease, such as asthma, PM~2.5~, PM~10~, and NO~2~ contribute to the hospitalization with certain effect size as shown by the RR, OR, or HR depending the type of the study design. The rest of the diseases with the certain type of pollutants that effect the admission are shown in Table [3](#T3){ref-type="table"} below.

###### 

The disease and the pollutant that effect the admission.

  ------------------ ----------- ----------------------------- -------------- ----------------------------
  Diseases           Pollutant   Study                         Study design   Effect

                                                                              

  Asthma             PM~2.5~     Chen et al. 2016              TS & CCO       RR 30.2% (13.4, 49.6)\
                                                                              OR 1.229 (1.139, 1.327)

                                 Cheng et al. 2015             CCO            OR 1.10 (1.06, 1.13)

                                 Iskandar et al. 2011          CCO            OR 1.09 (1.04, 1.13)

                     PM~10~      Chen et al. 2016              TS & CCO       RR 8.3% (2.5, 14.4)\
                                                                              OR 1.035 (1.007, 1.064)

                                 Cheng et al. 2015             CCO            OR 1.04 (1.03--1.06)

                                 Iskandar et al. 2011          CCO            OR 1.07 (1.03, 1.12)

                     NO~2~       Chen et al. 2016              TS & CCO       RR 12.5% (6.6, 18.7),\
                                                                              OR 1.077 (1.046, 1.109)

                                 Iskandar et al. 2011          CCO            OR 1.10 (1.04, 1.16)

                                 Andersen et al. 2012          Cohort         HR 1.12 (1.04, 1.22)

  COPD               PM~2.5~     Cheng et al. 2015             CCO            OR 1.11 (1.09, 1.13)

                                 Atkinson et al. 2014          Cohort         HR 1.05 (0.98, 1.13)

                     PM~10~      Cheng et al. 2015             CCO            OR 1.05 (1.03--1.06)

                     NO~2~       Atkinson et al. 2014          Cohort         HR 1.06 (0.98, 1.15)

                                 Andersen et al. 2011          Cohort         HR 1.08 (1.02, 1.14)

                                 Ghozikali et al. 2015         CCO            RR 1.0038 (1.0004, 1.0094)

                     SO~2~       Ghozikali et al. 2015         CCO            RR 1.0044 (1, 1.011)

                     Ozone       Ghozikali et al. 2015         CCO            RR 1.0058 (1.0022, 1.0094)

  Pneumonia          PM~2.5~     Cheng et al. 2015             CCO            OR 1.12 (1.11, 1.13)

                     PM~10~      Cheng et al. 2015             CCO            OR 1.05 (1.03--1.06)

  Ischaemic stroke   PM~2.5~     Hossein                       RCS            RR 1.09 (1.03, 1.15)

                     PM~10~      Alimohammadi et al. 2016      RCS            RR 1.14 (1.06, 1.22)

                                 Oudin et al. 2010             TS             RR 13% (4, 22)

                                 Vidale et al. 2010            TS             RR 1.078 (1.104, 1.052)

                     NO~2~       Alimohammadi et al. 2016      RCS            RR 1.07 (1.04, 1.1)

                                 Vidale et al. 2010            TS             RR 1.039 (1.066, 1.013)

                     SO~2~       Alimohammadi et al. 2016      RCS            RR 1.08 (1.06, 1.1)

                     Ozone       Alimohammadi et al. 2016      RCS            RR 1.07 (1.03, 1.11)

                                 Montresor-López et al. 2015   CCO            OR 0.98 (0.96, 1.00)
  ------------------ ----------- ----------------------------- -------------- ----------------------------

Discussion
==========

Main results and comparisons with existing literature
-----------------------------------------------------

Our systematic review of literature of 22 studies on the effect of air pollution and hospital admission showed that there are increasing risk of hospital admission for cardiovascular and respiratory group of diseases. Air pollution was believed to have influence only the respiratory disease such as asthma and COPD in the old studies in the 1990. However, in the early 2000, more studies were done to establish the connection of the air pollution with the cardiovascular disease as we have more understanding of the components in the air pollutant and the physiology that they can cause to the human body. Therefore, our study concurrent with the other study that state that air pollution cause higher risk of cardiovascular and respiratory disease hospitalization \[[@B30][@B31][@B32][@B33][@B34]\].

This paper also showed that the PM either the fine particulate (PM~2.5~) or coarse particulate (PM~10~) has a higher influence of hospital admission either in cardiovascular or respiratory disease than the other air pollutants. This was due to the fact that physiology of the PM that can penetrate deep into the lungs and heart and alters the autonomic control of the heart which lead to cardiovascular problem \[[@B35]\]. It also act as an irritant and induce defensive responses in the airways, such as increased mucus secretion and increased bronchial hyperactivity and lead to respiratory problem \[[@B36]\]. This finding is congruent with other studies as well stated that increased concentration of PM associated with hospitalization \[[@B30][@B31][@B32]\].

Weaknesses of our methodology
-----------------------------

Despite carrying out a comprehensive search some studies may have been missed to be included for this systematic review. However, by searching a number of different databases, with different indexing systems, and, furthermore, checking reference lists and the websites of major organisations, we believe that all major studies with hospital admission as the primary outcome have been picked up. In addition, there might have been publication bias: studies finding effects may have been more likely to be published. The extent of publication bias is difficult to assess in studies with such varied methodology and reporting. Though such concerns should always be borne in mind, our goal was not to produce a definitive numerical estimate of the effects of air pollution on hospital admission risk, but rather to give an overview of the evidence available. Finally, since we excluded non-English abstracts citations owing to resource limitations and may have missed some non-English full-text articles, we believe that this is unlikely to have led to the omission of any major papers in the area.

Impact of our results
---------------------

The result of this paper strongly supports the fact that the effect of air pollution is associated with the higher risk of hospital admission for cardiovascular and respiratory diseases. This is supported by several systemic reviews done previously \[[@B3][@B32][@B37]\]. It is plausible that morbidity and mortality from non-communicable diseases such as stroke and ischaemic heart disease, the impact of air pollution is also an important and act as modifiable risk factor \[[@B30][@B31]\]. Understanding this, it should give enough evidence to the policy makers to make same action and plan to reduce this effect.

Future research
---------------

The exact role of individual pollutants is still unclear, and perhaps only further experimental studies under controlled conditions can deal with this issue. There is also a need for biomarkers of exposure that can be used in epidemiological studies to give more reliable estimates of individual exposure to air pollutants. There is also a need for more studies that take into account the potential effect modifiers; though a few studies have presented stratified or age-restricted data, there is little direct evidence on how age, and other individual-level factors such as previous disease, affect a person's vulnerability. Finally, future studies are needed to ascertain factors contributing to why some people or indeed populations are more susceptible than others to the detrimental effects of air pollution.

Conclusion
==========

The exposure to air pollutants confers to an increased risk of hospital admission of several disease. Our findings call for greater awareness of environmental protection and the implementation of effective measures to improve the quality of air, which may reduce the risks of adverse effects on the population's health. Public and environmental health policies that aim to reduce air pollution levels might reduce the burden of multiple diseases such as stroke, asthma, and ischaemic heart diseases that are influenced by the air pollutants.

The author would like to thank you the dean of Faculty of Medicine, National University of Malaysia for permission and support in this research. Research code project number FF-2016-183.

Competing Interests
===================

The authors have no competing interests to declare.

Author Contribution
===================

All authors had access to the data and participate in writing the manuscript.
